ARTICLE | Company News
Eisai, Glenmark neurology news
May 11, 2015 7:00 AM UTC
Eisai and Glenmark settled patent litigation relating to Eisai’s Banzel rufinamide for seizures. Under the settlement terms, Glenmark will be permitted to market a generic version of Banzel in the U....